Role of BCR in the resistance of BCR/ABL harboring the T315I mutation

被引：0
|
作者：
Rafiei, A. [1 ]
Metodieva, A. T. [1 ]
Ottmann, O. G. [1 ]
Serve, H. [1 ]
Ruthardt, M. [1 ]
Mian, A. A. [1 ]
机构：
[1] Goethe Univ Frankfurt, Med Klin 2, Frankfurt, Germany
来源：
ONKOLOGIE | 2011年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [1] THE TRANSPHOSPHORYLATION OF BCR IN THE RESISTANCE OF BCR/ABL HARBORING THE T315I MUTATION
    Ruthardt, M.
    Mian, A.
    Metodieva, A.
    Rafiei, A.
    Serve, H.
    Ottmann, O.
    Ruthardt, M.
    HAEMATOLOGICA, 2012, 97 : 2 - 2
  • [2] Addressing BCR/Abl resistance: Evolving dasatinib to a novel inhibitor of the T315I BCR/Abl mutation
    Zhu, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] A Pyrosequencing Based Test for Quantitative Monitoring of the BCR ABL T315I Mutation
    Schumacher, J. A.
    Szankasi, P.
    Ho, A. K.
    Kelley, T. W.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 869 - 869
  • [4] Quantitative monitoring of BCR-ABL mRNA harboring the T315I mutation in chronic myeloid leukemia (CML)
    Chomel, Jean-Claude
    Sorel, Nathalie
    Guilhot, Francois
    Turhan, Ali G.
    BLOOD, 2007, 110 (11) : 858A - 858A
  • [5] Quantitative monitoring of T315I BCR-ABL mutation by the invader assay
    Kakihana, Kazuhiko
    Ohashi, Kazuteru
    Najima, Yuho
    Kikuchi, Taku
    Nagata, Yasunobu
    Ueki, Toshimitsu
    Kobayashi, Takeshi
    Yamashita, Takuya
    Akiyama, Hideki
    Yamaguchi, Toshikazu
    Sakamaki, Hisashi
    BLOOD, 2007, 110 (11) : 207B - 207B
  • [6] Transphosphorylation of Endogenous BCR Mediates the Effect of T315I on the Transformation Potential of BCR/ABL
    Mian, Afsar
    Haberbosch, Isabella
    Ottmann, Oliver G.
    Ruthardt, Martin
    BLOOD, 2014, 124 (21)
  • [7] Anti-leukemic activity of axitinib against cells harboring the BCR-ABL T315I point mutation
    Seiichi Okabe
    Tetsuzo Tauchi
    Yuko Tanaka
    Juri Sakuta
    Kazuma Ohyashiki
    Journal of Hematology & Oncology, 8
  • [8] Anti-leukemic activity of axitinib against cells harboring the BCR-ABL T315I point mutation
    Okabe, Seiichi
    Tauchi, Tetsuzo
    Tanaka, Yuko
    Sakuta, Juri
    Ohyashiki, Kazuma
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
  • [9] Pathological role of a point mutation (T315I) in BCR-ABL1 proteinA computational insight
    Rajendran, Vidya
    Gopalakrishnan, Chandrasekhar
    Sethumadhavan, Rao
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (01) : 918 - 925
  • [10] Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias
    Nicolini, Franck Emmanuel
    Basak, Grzegorz W.
    Soverini, Simona
    Martinelli, Giovanni
    Mauro, Michael J.
    Mueller, Martin C.
    Hochhaus, Andreas
    Chuah, Charles
    Dufva, Inge H.
    Rege-Cambrin, Giovanna
    Saglio, Giuseppe
    Michallet, Mauricette
    Labussiere, Helene
    Morisset, Stephane
    Hayette, Sandrine
    Etienne, Gabriel
    Olavarria, Eduardo
    Zhou, Wei
    Peter, Senaka
    Apperley, Jane F.
    Cortes, Jorge
    BLOOD, 2011, 118 (20) : 5697 - 5700
12345